Physio-Friendly Remission-Facilitating Pharmacotherapy (PRP) in Type 2 Diabetes.

IF 0.8 4区医学 Q3 MEDICINE, GENERAL & INTERNAL

Journal of the Pakistan Medical Association Pub Date : 2024-11-01 DOI:10.47391/JPMA.24-89

Sanjay Kalra, Suneet Verma, Nitin Kapoor

引用次数: 0

Abstract

This brief communication describes the concept of physiofriendly pharmacotherapy for type 2 diabetes mellitus. Physio-friendly therapy is defined as that which restores metabolic, including glycaemic and weight homoeostasis, to near normal levels. Drugs such as glucagon like peptide 1 receptor agonists (GLP1RA), sodium glucose cotransporter- 2 inhibitors (SGLT2i), and alfa glucosidase inhibitors, along with metformin, work in a physio-friendly manner and may facilitate remission. Thus, they can also be termed as remission-facilitating drugs.

查看原文本刊更多论文

2 型糖尿病患者的物理缓解促进药物疗法 (PRP)。

本简讯介绍了针对 2 型糖尿病的物理友好药物疗法的概念。物理友好疗法的定义是将代谢（包括血糖和体重平衡）恢复到接近正常水平的疗法。胰高血糖素样肽 1 受体激动剂（GLP1RA）、钠葡萄糖共转运体 2 抑制剂（SGLT2i）和α葡萄糖苷酶抑制剂等药物与二甲双胍一起以物理友好的方式发挥作用，可促进病情缓解。因此，它们也可被称为缓解促进药物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of the Pakistan Medical Association Medicine-General Medicine

CiteScore

1.10

自引率

11.10%

发文量

983

审稿时长

3-6 weeks

期刊介绍： Primarily being a medical journal, JPMA publishes scholarly research focusing on the various fields in the areas of health and medical education. It publishes original research describing recent advances in health particularly clinical studies, clinical trials, assessments of pathogens of diagnostic importance, medical genetics and epidemiological studies. Review articles highlighting importance of various issues in the domain of public health, drug research and medical education are also accepted. As a leading journal of South Asia, JPMA remains cognizant of the recent advances in the rapidly growing fields of biomedical sciences, it invites and encourages scholars to write short reviews and invited editorials on the emerging issues. We particularly aim to promote health standards of developing countries by encouraging manuscript submissions on issues affecting the public health and health delivery services.